Announcement
Sativa Group PLC : Launch of cannabinoid CBG hand cleanser
RNS Number : 4972G
Sativa Group PLC
17 March 2020
|
Press Release
|
17 March 2020
|
Sativa Group Plc
("Sativa" or "the Company")
Launch of cannabinoid cannabigerol (CBG) hand cleanser
Sativa Group Plc [NEX: SATI], the UK's leading quoted CBD wellness and medicinal cannabis Group, has commenced production of a cannabigerol (CBG) and alcohol-based hand cleanser in response to the increased need for hand sanitation as a result of Covid-19.
Existing research and commercially available products show evidence that CBG is an effective antibacterial agent and is also believed to be effective in combatting MRSA, one of the most common hospital superbugs. As the Company continues its research, other formats may become available as we work with our supply chain to source all necessary raw materials. The hand cleanser is expected to be available for sale in approximately ten days, subject to the Company receiving packaging and labelling as planned.
George Thomas, Managing Director of Sativa subsidiary Goodbody Botanicals, said: "CBG has already proven itself as impactful in terms of combatting germs and, when coupled with alcohol, makes it an ideal hand cleanser. We are pleased to be able to supply what, we hope, will be a tool in combatting the spread of this virus."
"The UK and the world is facing a health crisis and at Sativa, while we are continuing focus on making the highest quality products and building the UK's leading CBD Wellness brands, we have prioritized new product development to help people in this period", said Henry Lees-Buckley, CEO of the Sativa Group.
- Ends -
Media enquiries.
|
Abchurch Communications Julian Bosdet +44 (0)207 4594 4070 +44 (0) 7771 663 886 |
|
For further information please contact:
|
Henry Lees-Buckley Chief Executive Officer Sativa Group Plc +44 (0) 20 7971 1255
|
Joseph Colliver Chief Financial Officer Sativa Group Plc +44 (0) 20 7971 1255
|
|
NEX Exchange Corporate Adviser
Corporate Finance Stephen Keys / Max Gould Cenkos Securities plc +44 (0) 20 7397 8900 |
Equity Sales Julian Morse Cenkos Securities +44 (0) 20 7397 8900 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
NRAMZGMFKNKGGZM
;